Sound Energy PLC (SOU:AIM) delivered its Interim Results Investor Presentation highlighting significant progress towards production and long-term growth in Morocco’s energy sector. The company confirmed it is on track for first gas from its Tendrara LNG project by year-end, supported by fully tested wells, commissioning of the micro-LNG plant, and a 10-year take-or-pay offtake agreement with Afriquia Gas. Phase two, a pipeline-led expansion with partner Mana Energy, is advancing with feed studies underway and expected to generate c.$90 million annual revenue, taking combined phase one and two revenues to an estimated $120 million, with Sound holding a 20% stake. The company emphasized Morocco’s strong demand fundamentals, attractive fiscal regime, and strategic position in the transition energy market, supported by exploration upside across 23,000 km² of acreage and two fully funded exploration wells. Beyond gas, Sound is diversifying into renewables through joint ventures in natural hydrogen (High Moroc with GTech) and solar energy (Gaia Energy), targeting up to 300 MW capacity. CFO Andy Matharu outlined priorities around achieving operational cash flow, strengthening the balance sheet, and pursuing new ventures across North Africa. Management reiterated that financing is secure, exploration and development are fully funded, and news flow on commissioning, drilling, and contracts will drive near-term catalysts. With robust partnerships, long-term revenue visibility, and diversification into renewables, Sound Energy positions itself as a key growth story in Morocco’s evolving energy landscape.

Mission Group PLC (TMG:AIM) delivered its Interim Results investor update highlighting resilience, strategic focus, and improved profitability despite market headwinds. Newly appointed CEO John Kerry outlined a renewed customer-centric growth strategy, emphasizing simplification, prioritization, and leveraging the Group’s strong client relationships and leadership expertise. Operationally, Mission has streamlined its structure from 19 agencies to five core segments, cut central costs, and integrated AI and system upgrades to enhance efficiency and margins. For H1 2025, revenue declined 4% to £36.6m in line with sector trends, but operating profit rose 15% through restructuring savings, with profit before tax doubling year-on-year on a like-for-like basis. Net debt reduced by £8m versus the prior year, supported by a new three-year banking facility. Segment performance was mixed: business-to-business and property delivered solid growth, consumer markets remained challenging, while sports and entertainment showed strong pipeline potential for H2. Management reaffirmed its ambition to lift Group margins to 14–15% through continued cost discipline, cross-agency collaboration, and high-margin digital and AI-driven offerings. Looking ahead, Mission sees significant opportunities to unlock value across its portfolio, strengthen client partnerships, and expand internationally. While near-term trading remains tough, the Group is on track with expectations and well-positioned for medium-term growth, with a Capital Markets Day planned for early 2026 to detail strategy and segmental ambitions.

Polarian Imaging PLC (POLX:AIM) delivered its latest investor update, highlighting progress with its FDA-approved Xenon MRI platform, the only non-invasive, radiation-free imaging technology that provides a full picture of lung function. While first-half 2025 revenue guidance was revised down to $2.5–3.5m due to US academic funding headwinds, the company reported 36% growth in consumable sales and a significant new NIH order, underscoring customer adoption and commercial momentum. Polarian is advancing its five-pillar growth strategy: driving utilization, expanding its customer base, strengthening reimbursement, broadening its addressable market, and building partnerships. Recent milestones include expanded pediatric approval, a growing pipeline of pharma-sponsored trials, and international progress in Asia Pacific. The company is funded through Q2 2026 with $7.3m in cash and no debt, and anticipates a return to its $5–6m revenue trajectory in 2026 as market conditions stabilize. Looking ahead, Polarian is preparing a pivotal gas exchange Phase 3 trial at a reduced cost of $4–4.5m, which could unlock broader label expansion and accelerate profitability with an estimated $20m incremental investment. With more than 1,000 supporting publications and deep collaborations with MRI leaders Philips, GE, and Siemens, Polarian continues to strengthen its order book, pipeline, and clinical validation, positioning its platform at the forefront of pulmonary imaging innovation and long-term EBITDA growth potential.

GTech Group PLC (GTC:AIM) delivered its Interim Results 2025 investor presentation, highlighting steady revenues of £2.1m, a strengthened order book rising to £4.2m, and progress on cost reductions expected to deliver a 20% annualized saving. The Group completed the sale-and-leaseback of its final office, leaving it debt-free with a £0.4m cash balance. Core growth is driven by its flagship GLOBE platform, securing multi-year renewals with supermajor energy clients and integrating advanced AI and machine learning features. Expansion in unconventional oil and gas software continues to attract both operators and financial institutions, particularly in the U.S. market. GTech also advanced its natural hydrogen strategy through a 50:50 joint venture with Sound Energy in Morocco and a partnership with seismic technology firm Stride, positioning the Group at the forefront of hydrogen, helium, and subsurface exploration opportunities. Strategic priorities remain focused on scaling annual recurring revenue (ARR) through GLOBE and software sales, with clear potential for margin expansion as subscriptions grow. The company’s proprietary geoscience datasets and IP, built over three decades, underpin its competitive advantage across oil and gas, mining, and critical minerals markets. Looking ahead, management reiterated its 2025 turnaround plan, targeting EBITDA profitability for the first time in over five decades, supported by a stronger sales pipeline, renewed governance, and ongoing innovation in digital geoscience solutions. GTech sees long-term demand for upstream investment and resource discovery as key market drivers, providing confidence in revenue growth, JV upside potential, and delivery of sustainable shareholder value.

N4 Pharma PLC (AIM: N4P) has released its interim results and provided investors with a detailed strategy update focused on the advancement and commercialisation of its proprietary Nuvec® delivery platform for RNA therapeutics. Operating in a rapidly expanding global RNA therapeutics market, forecast to reach $18bn, the company highlighted strong progress with its lead program N4-101 for inflammatory bowel disease, demonstrating positive in vivo efficacy, dual RNA payload delivery, and oral administration potential. Nuvec® offers key advantages over lipid nanoparticles and viral vectors, including targeted delivery to specific cells and tissues, multi-payload capacity, protection against RNA degradation, ease of manufacturing, and stability at room temperature — positioning it as a next-generation RNA delivery system. The company strengthened its cash position through a £1.7m fundraise, reduced operating losses, and reinforced its leadership team with experienced biotech executives to accelerate partnering discussions. Ongoing collaborations, including with the University of Strathclyde, are generating comparative data against existing lipid-based platforms, with the goal of building a comprehensive commercial data package to secure licensing and co-development agreements. Management emphasised Nuvec®’s potential across oncology and other therapeutic areas, underpinned by strong patent protection and opportunities for new IP creation. With a clear growth strategy, strengthened governance, and a compelling investment case at an early stage of the biotech value curve, N4 Pharma is positioning itself to unlock significant long-term value through partnerships, platform licensing, and future pipeline expansion.

Hamak Gold Limited (HAMA:LSE) delivered its first investor update outlining a dual growth strategy in gold exploration and digital asset treasury management. The company confirmed a strong balance sheet with over a year of cash reserves and highlighted its focus on long-term shareholder value through diversification into gold and Bitcoin. In Liberia, Hamak is advancing its Nimba gold project via a joint venture with First AU Limited, which has already delivered high-grade drill results and is fully funded for a 3,000m drilling programme, with maiden resource potential expected in 2026. The agreement secures milestone payments in both cash and shares, positioning Hamak as a significant shareholder in First AU while retaining exposure to gold upside. Alongside gold, Hamak is building a Bitcoin treasury policy, to be unveiled in October, with input from economist Dr. Arthur Laffer. The strategy focuses on steady accumulation, yield generation, and smart balance sheet management to create a £100m+ asset base, supported by potential M&A opportunities in both mining and digital assets. Management emphasised its world-class board, robust funding pipeline, and commitment to disciplined deal-making, ensuring that future equity or funding arrangements deliver clear value without unnecessary dilution. Looking ahead, Hamak aims to expand its gold portfolio across Africa, strengthen its Bitcoin treasury, and leverage strategic partnerships to differentiate itself from peers. With a dual-asset model, international growth plans, and a focus on EBITDA-positive, cash-generative operations, the company targets long-term shareholder returns, positioning itself as a unique LSE-listed vehicle bridging traditional commodities and digital assets.

CQS New City High Yield Fund Limited (LSE:NCYF) reported resilient full year results for the period ended 30 June 2025, delivering a net asset value (NAV) total return of 6.98% and a share price total return of 7.43%, despite weaker global bond markets. The Fund maintained its long-standing record of dividend growth, increasing payouts to 4.51 pence per share, equivalent to an 8.77% yield at year-end, supported by strong reserves and a disciplined closed-ended structure. Portfolio manager Ian Francis highlighted the Fund’s short duration strategy, with an average maturity of just over three years, which reduces sensitivity to interest rate volatility while maintaining attractive yields above 8%. The portfolio remains diversified across financials, consumer staples, real estate, and selective high-yield equities, with notable holdings in Stonegate, Shawbrook, Royal London, and NextEnergy Solar Fund. During the year, the Fund issued over £33 million of new shares—more than 10% of portfolio value—reflecting sustained investor demand and enhanced liquidity. Since year-end, share price total return has risen a further 3.9%, with rolling 12-month returns of 9.25%. Management emphasised succession planning, robust credit analysis via Manulife CQS, and continued focus on delivering high income with disciplined risk management. With a strong order book of high-yield opportunities, consistent dividend policy, and loyal retail investor base, the Fund remains well-positioned to generate income and total return, while navigating market risks such as inflation, interest rates, and geopolitical uncertainty.

Microlise Group plc (SAAS:AIM) delivered a strong interim 2025 performance, reporting revenue growth of 12.6% to £44.1m and a 19% increase in EBITDA to £6.2m, with margins improving to 14.1%. Annual recurring revenue rose 8.7% to £58.7m, underpinned by 216 new customer wins and exceptionally low churn at 0.5%. Recurring revenue reached £29.5m, up 11.1%, while hardware sales grew 15% to £10.1m, supported by major rollouts. Services revenue also advanced to £4.4m, reflecting higher installation and integration activity. Management emphasised ongoing margin enhancement through direct sales growth, product cost efficiencies, and streamlined rollout processes that accelerate order book conversion and cash generation. Post-period, Microlise strengthened its balance sheet with £2.2m proceeds from the Trackmate disposal, adding to £40m of available funding for M&A. Strategic highlights included progress on international expansion with compliance support in Australia and France, stronger cybersecurity investment following a successful NIST audit, and deeper product integration to drive cross-sell opportunities. Despite headwinds from cyber incidents and automotive sector volatility, management reaffirmed confidence in long-term growth, supported by sticky customer relationships, five-year contracts, and significant white space within its installed base—where full adoption of Microlise’s solutions could more than quintuple recurring revenues. With robust cash flow, disciplined M&A ambitions, and an expanding AI-driven product suite, Microlise is positioned to deliver sustained revenue growth, rising EBITDA margins, and increasing shareholder value.

Seeing Machines Limited (SEE:AIM) delivered its FY25 results presentation, reaffirming its strategy to drive revenue growth, improve margins, and reach cash flow breakeven by the end of calendar 2025. The company reported a 30% increase in automotive royalty revenue, supported by regulatory momentum in Europe where new safety rules (GSR) mandate camera-based driver monitoring systems in all vehicles from July 2026. With around 50% market share on a production basis, management highlighted significant growth in royalty streams, underpinned by multi-year OEM contracts and minimum guaranteed royalty agreements worth over $40m.

The Guardian aftermarket product is transitioning to Gen 3, offering higher margins and stronger recurring revenue opportunities across North America, Europe, and Asia-Pacific, with Mitsubishi partnership channels expected to accelerate adoption. Aerospace remains a long-term opportunity through collaborations with Collins and simulator providers.

Management emphasized that the heavy investment phase is complete, with an embedded $8.6m cost reduction program improving the operating base. The business is on track to achieve profitability, supported by a robust order book, strong pipeline of RFQs, and expanding partnerships with tier-one suppliers such as Magna, Valeo, Caterpillar, and Mitsubishi.

CEO Paul McGlone and CFO Martin Ive reinforced guidance of high double-digit revenue growth for FY26, margins above 60%, and cash generation from H2 FY26. Looking ahead, management sees substantial upside from regulatory-driven demand, growing OEM penetration, and new adjacent markets identified with Mitsubishi, including insurance and smart factory applications.

With a cash balance of $22m, a path to profitability, and regulatory tailwinds, Seeing Machines positions itself as a global leader in driver and occupant monitoring technology, focused on delivering long-term shareholder value.

Saga PLC (SAGA:LSE) delivered a strong H1 2025 performance, with revenue growth, profits ahead of expectations, and net debt reduced by £102m to £515.1m. Travel remains the group’s largest profit driver, delivering a 33% increase in underlying PBT to £41.6m, supported by robust demand across ocean and river cruises, higher load factors, and rising per diems. Insurance broking also outperformed expectations, returning policy growth across motor, travel, and private medical lines. Group EBITDA rose 8%, and available operating cash flow increased 64% to £89.4m, underpinning further deleveraging with a leverage ratio of 4.3x. Strategic execution advanced with the refinancing of 2026 debt, completion of the underwriting sale (£17m ahead of forecast), and preparations for the Aeges insurance partnership and NatWest Box venture. Management reaffirmed its medium-term profit target of £100m and leverage below 2x by 2030, highlighting progress towards a simplified, lower-risk model with more predictable earnings. Travel growth remains central, with strong forward bookings in ocean cruises, expansion of the river cruise fleet including the launch of Spirit of the Moselle, and a refocus on differentiated holiday experiences tailored to Saga’s over-50 customer base. Insurance is transitioning to a commission-based, capital-light model, while customer engagement is being strengthened through publishing, digital channels, and new products such as Saga Wine Club and Saga Connections. With high customer satisfaction scores, growing strategic partnerships, and clear visibility on debt reduction, Saga is well-positioned for sustainable growth, improved margins, and shareholder value creation.